Clinical Trial Update: Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of ramelteon and doxepin in adults with chronic insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Doxepin (Doxepin)
• Ramelteon (Rozerem) (ramelteon)

Snippet

Sponsor: Takeda | Conditions: Sleep Initiation and Maintenance Disorders | Phase 2 | Status: COMPLETED